SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Nu Skin Enterprises, Inc. (NUS) trades at a trailing P/E of 2.3, forward P/E of 7.7. Trailing earnings yield is 44.12%, forward earnings yield 12.92%. PEG 0.25 (Peter Lynch undervalued ≤1.0). Graham Number is $35.07.
Criteria proven by this page:
- VALUE (98/100, Pass) — P/E is below market average (2.3); PEG ≤ 1.0 — Peter Lynch undervalued (0.25); analyst target implies upside (+42.1%); earnings yield beats bond yields (44.12%).
- PEG Ratio 0.25 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 44.12% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
- Analyst consensus target $11.00 (+42.1% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 62/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
98/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NUS
Valuation Multiples
P/E (TTM)2.3
Forward P/E7.7
PEG Ratio0.25
Forward PEG0.25
P/B Ratio0.45
P/S Ratio0.24
EV/EBITDA1.8
Per Share Data
EPS (TTM)$3.30
Forward EPS (Est.)$1.00
Book Value / Share$16.58
Revenue / Share$30.57
FCF / Share$0.95
Yields & Fair Value
Earnings Yield44.12%
Forward Earnings Yield12.92%
Dividend Yield3.21%
Graham Number$35.07
SharesGrow IV$19.32 (+149.6%)
Analyst Target$11.00 (+42.1%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
18.5 |
1.46 |
3.99 |
1.20 |
2.96% |
| 2017 |
27.8 |
-5.52 |
5.11 |
1.58 |
2.11% |
| 2018 |
27.8 |
-2.83 |
4.33 |
1.26 |
2.38% |
| 2019 |
13.1 |
0.31 |
2.60 |
0.94 |
3.61% |
| 2020 |
14.9 |
0.88 |
3.19 |
1.11 |
2.74% |
| 2021 |
17.3 |
-0.87 |
2.79 |
0.94 |
2.99% |
| 2022 |
20.1 |
-0.71 |
2.35 |
0.95 |
3.65% |
| 2023 |
112.3 |
-1.22 |
1.17 |
0.49 |
8.04% |
| 2024 |
-2.3 |
0.00 |
0.53 |
0.20 |
3.49% |
| 2025 |
3.0 |
-0.01 |
0.59 |
0.32 |
2.50% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$2.55 |
$2.21B |
$143.09M |
6.5% |
| 2017 |
$2.36 |
$2.28B |
$129.44M |
5.7% |
| 2018 |
$2.16 |
$2.68B |
$121.89M |
4.5% |
| 2019 |
$3.10 |
$2.42B |
$173.55M |
7.2% |
| 2020 |
$3.63 |
$2.58B |
$191.36M |
7.4% |
| 2021 |
$2.86 |
$2.7B |
$147.27M |
5.5% |
| 2022 |
$2.07 |
$2.23B |
$104.78M |
4.7% |
| 2023 |
$0.17 |
$1.97B |
$8.6M |
0.4% |
| 2024 |
$-2.95 |
$1.73B |
$-146.59M |
-8.5% |
| 2025 |
$3.18 |
$1.49B |
$160.2M |
10.8% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$1.00 |
$1.00 – $1.00 |
$1.43B |
$1.43B – $1.43B |
1 |
| 2027 |
$1.31 |
$1.31 – $1.31 |
$1.53B |
$1.53B – $1.53B |
1 |
